Proton pump inhibitor therapy improves symptoms in postnasal drainage - PubMed (original) (raw)
Randomized Controlled Trial
. 2010 Dec;139(6):1887-1893.e1; quiz e11.
doi: 10.1053/j.gastro.2010.08.039. Epub 2010 Aug 27.
David D Hagaman, James C Slaughter, S Bobo Tanner, James A Duncavage, Christine T Allocco, Christy Sparkman, Lynn E Clement, Cynthia M Wasden, Dana Wirth, Marion Goutte, Barbara A McCafferty, Donald C Lanza
Affiliations
- PMID: 20801120
- DOI: 10.1053/j.gastro.2010.08.039
Randomized Controlled Trial
Proton pump inhibitor therapy improves symptoms in postnasal drainage
Michael F Vaezi et al. Gastroenterology. 2010 Dec.
Abstract
Background & aims: Gastroesophageal reflux is common among patients with postnasal drainage. We investigated whether proton pump inhibitor therapy improved symptoms in patients with postnasal drainage without sinusitis or allergies.
Methods: In a parallel-group, double-blind, multi-specialty trial, we randomly assigned 75 participants with continued symptoms of chronic postnasal drainage to groups that were given 30 mg of lansoprazole twice daily or placebo. Participants were followed up for 16 weeks. Symptoms were assessed at baseline and after 8 and 16 weeks. Ambulatory pH and impedance monitoring assessed presence of baseline reflux. The primary objective of the study was to determine if acid suppressive therapy improved postnasal drainage symptoms. The secondary objective was to assess if pH and impedance monitoring at baseline predicted response to treatment.
Results: Postnasal drainage symptoms improved significantly among patients given lansoprazole compared with placebo. After 8 and 16 weeks, participants given lansoprazole were 3.12-fold (1.28-7.59) and 3.50-fold (1.41-8.67) more likely to respond, respectively, than participants given placebo. After 16 weeks, median (interquartile) percent symptom improvements were 50.0% (10.0%-72.0%) for participants given lansoprazole and 5.0% (0.0%-40.0%) for participants given placebo (P = .006). Neither baseline presence of typical reflux symptoms nor esophageal physiologic parameters predicted response to therapy.
Conclusions: Among participants with chronic postnasal drainage without evidence of sinusitis and allergies, twice-daily therapy with proton pump inhibitors significantly improved symptoms after 8 and 16 weeks. The presence of heartburn, regurgitation, abnormal levels of esophageal acid, or nonacid reflux did not predict response to therapy.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
- Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB, Boparai V, Ullah N, Triadafilopoulos G. Gerson LB, et al. Aliment Pharmacol Ther. 2004 Sep 15;20(6):637-43. doi: 10.1111/j.1365-2036.2004.02127.x. Aliment Pharmacol Ther. 2004. PMID: 15352912 - The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
Bilgen C, Ogüt F, Kesimli-Dinç H, Kirazli T, Bor S. Bilgen C, et al. J Laryngol Otol. 2003 May;117(5):386-90. doi: 10.1258/002221503321626438. J Laryngol Otol. 2003. PMID: 12803789 - Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. Miyamoto M, et al. J Gastroenterol Hepatol. 2007 May;22(5):639-44. doi: 10.1111/j.1440-1746.2007.04871.x. J Gastroenterol Hepatol. 2007. PMID: 17444849 Clinical Trial. - Gastroesophageal reflux and chronic rhinosinusitis.
Hanna BC, Wormald PJ. Hanna BC, et al. Curr Opin Otolaryngol Head Neck Surg. 2012 Feb;20(1):15-8. doi: 10.1097/MOO.0b013e32834e8f11. Curr Opin Otolaryngol Head Neck Surg. 2012. PMID: 22157165 Review. - Review article: alternative approaches to the long-term management of GERD.
Fennerty MB. Fennerty MB. Aliment Pharmacol Ther. 2005 Dec;22 Suppl 3:39-44. doi: 10.1111/j.1365-2036.2005.02711.x. Aliment Pharmacol Ther. 2005. PMID: 16303036 Review.
Cited by
- Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach.
Abou-Ismail A, Vaezi MF. Abou-Ismail A, et al. Curr Gastroenterol Rep. 2011 Jun;13(3):213-8. doi: 10.1007/s11894-011-0184-x. Curr Gastroenterol Rep. 2011. PMID: 21360069 Review. - Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
Fossmark R, Ness-Jensen E, Sørdal Ø. Fossmark R, et al. BMC Gastroenterol. 2023 Sep 6;23(1):303. doi: 10.1186/s12876-023-02945-7. BMC Gastroenterol. 2023. PMID: 37674110 Free PMC article. Review. - Causal association of gastroesophageal reflux disease with chronic sinusitis and chronic disease of the tonsils and adenoids.
Li W, Zhang Y, Li X, Xie M, Dong L, Jin M, Lu Q, Zhang M, Xue F, Jiang L, Yu Q. Li W, et al. Eur Arch Otorhinolaryngol. 2024 Jun;281(6):2975-2984. doi: 10.1007/s00405-023-08435-6. Epub 2024 Jan 13. Eur Arch Otorhinolaryngol. 2024. PMID: 38217725 - Endoscopy in Extraesophageal Manifestations Secondary to Gastroesophageal Reflux Disease: Why Do We Insist?
Macedo C, Almeida N. Macedo C, et al. GE Port J Gastroenterol. 2020 Aug;27(5):302-303. doi: 10.1159/000507637. Epub 2020 May 14. GE Port J Gastroenterol. 2020. PMID: 32999901 Free PMC article. No abstract available. - Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet.
Katzka DA, Pandolfino JE, Kahrilas PJ. Katzka DA, et al. Clin Gastroenterol Hepatol. 2020 Apr;18(4):767-776. doi: 10.1016/j.cgh.2019.07.015. Epub 2019 Jul 15. Clin Gastroenterol Hepatol. 2020. PMID: 31319183 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources